Mylotarg and blood alkaline phosphatase increased 
Mylotarg and blood alkaline phosphatase increased Patient Reports March 22, 2010
Mylotarg Side Effects Report #4774007-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 07, 2005. Male patient, 70 years of age, was diagnosed with myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood creatine increased, chest x-ray abnormal, dyspnoea, haemoglobin decreased, haemorrhage. Mylotarg dosage: 7 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ARSENIC TRIOXIDE, PRINIVIL, VITAMINS, TRICOR. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5059006-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 10, 2006. Female patient, 63 years of age, weighting 108.0 lb, was diagnosed with chronic myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal tenderness, activated partial thromboplastin time prolonged, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased. Mylotarg dosage: 13 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, GEMCITABINE, NOVANTRONE, DIFLUCAN, DILAUDID, ATIVAN, LEVAQUIN, INSULIN. Patient was hospitalized. Patient died on 04/02/2003.
Mylotarg Side Effects Report #5123334-4
Mylotarg side effect was reported by a Health Professional from JAPAN on Sept 25, 2006. Female patient, 78 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, conjunctival haemorrhage, febrile neutropenia, haematuria, hepatomegaly. Mylotarg dosage: unknown. During the same period patient was treated with AMLODIPINE BESYLATE, LOSARTAN POTASSIUM, SULFAMETHOXAZOLE, FLUCONAZOLE, FAMOTIDINE, MUCOSTA, POLYMYXIN B SULPHATE. Patient recovered.
Mylotarg Side Effects Report #4937095-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Feb 17, 2006. Male patient, 78 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, bone marrow failure, condition aggravated, febrile neutropenia. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with MODACIN, SULPERAZON, TIENAM, CIPROFLOXACIN HYDROCHLORIDE, MEROPEN, PRODIF, POLYMYXIN B SULPHATE. Patient recovered.
Mylotarg Side Effects Report #5217083-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 11, 2007. Male patient, 70 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, blood alkaline phosphatase increased, blood pressure increased, c-reactive protein increased, fibrin degradation products increased, hepatic function abnormal, nausea
, neutrophil count decreased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE; SEE IMAGE. During the same period patient was treated with TSUKUSHI AM, ISODINE, POLYMYXIN B SULPHATE, ITRACONAZOLE, FAMOTIDINE, NITRAZEPAM, SOLITA T. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5062123-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on July 10, 2006. Male patient, 70 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, bacteraemia, blood alkaline phosphatase increased, blood pressure increased, c-reactive protein increased, fibrin degradation products increased, hepatic function abnormal, nausea
, neutrophil count decreased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with TSUKUSHI AM, ISODINE, POLYMYXIN B SULPHATE, ITRACONAZOLE, FAMOTIDINE, NITRAZEPAM. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5105263-5
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Aug 29, 2006. Male patient, 70 years of age, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, condition aggravated, dyspnoea, infusion related reaction, international normalised ratio increased, pyrexia, thrombocytopenia. Mylotarg dosage: unknown. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, MORPHINE SULPHATE, AMBIEN, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5146283-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 24, 2006. Male patient, 70 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, bacteraemia, blood alkaline phosphatase increased, blood culture positive, blood pressure increased, c-reactive protein increased, fibrin degradation products increased, hepatic function abnormal, nausea
. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with TSUKUSHI AM, ISODINE, POLYMYXIN B SULPHATE, ITRACONAZOLE, FAMOTIDINE, NITRAZEPAM, SOLITA T. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4977021-3
Mylotarg side effect was reported by a Physician from UNITED STATES on Mar 30, 2006. Male patient, 70 years of age, weighting 180.2 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, chills, condition aggravated, dyspnoea, infusion related reaction, international normalised ratio increased, pyrexia. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, MORPHINE SULPHATE, AMBIEN, TYLENOL, ZOSYN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5086082-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 04, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia recurrent, sinusitis
and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, blast cell count increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, chills, disseminated intravascular coagulation, gamma-glutamyltransferase increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CARBENIN, LEVOFLOXACIN, VANCOMYCIN HYDROCHLORIDE, VFEND, ZANTAC, MUCOSTA, URSO. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5119945-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Sept 22, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood calcium decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium decreased, blood urea increased, gamma-glutamyltransferase increased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, DIFLUCAN, CLARITHROMYCIN, FAMOTIDINE, MUCOSTA, FEPRAZONE. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #4942761-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 01, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, diarrhoea, haemoglobin decreased, herpes zoster, hypokalaemia, malignant neoplasm progression. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE, SULFAMETHOXAZOLE, TIENAM. Patient died.
Mylotarg Side Effects Report #4991409-6
Mylotarg side effect was reported by a Physician from JAPAN on Apr 25, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, bacterial infection
, blood alkaline phosphatase increased, blood pressure decreased, depressed level of consciousness, diarrhoea. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE, SULFAMETHOXAZOLE, TIENAM, MAXIPIME. Patient died.Mylotarg Side Effects Report #4992456-0
Mylotarg side effect was reported by a Health Professional from JAPAN on Apr 19, 2006. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, infection
, liver disorder, multi-organ failure, renal disorder. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE, INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, ACLACINON. Patient died.Mylotarg Side Effects Report #5053133-3
Mylotarg side effect was reported by a Health Professional from JAPAN on June 29, 2006. Female patient, 56 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blast cell count increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, coagulation factor xiii level decreased, condition aggravated, disease progression, febrile neutropenia. Mylotarg dosage: A SINGLE 7 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with ROXATIDINE ACETATE, ZOFRAN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5104160-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 29, 2006. Male patient, 56 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood pressure decreased, body temperature decreased, disseminated intravascular coagulation, gamma-glutamyltransferase increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP; 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with OMEPRAZOLE, MAXIPIME, AMIKACIN SULPHATE, MEROPENEM, TIENAM, CIPROXAN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4958936-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 15, 2006. Female patient, 56 years of age, was diagnosed with acute myeloid leukaemia recurrent, chloroma and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blast cell count increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, coagulation factor xiii level decreased, fibrin degradation products increased, gamma-glutamyltransferase increased, gastrointestinal haemorrhage, performance status decreased. Mylotarg dosage: A SINGLE 7 MG/M^2 DOSE, INTRAVENOUS DRIP. During the same period patient was treated with ROXATIDINE ACETATE, ORGARAN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5019634-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 22, 2006. Female patient, 56 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blast cell count increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, coagulation factor xiii level decreased, condition aggravated, disease progression, febrile neutropenia. Mylotarg dosage: A SINGLE 7 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with ROXATIDINE ACETATE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5151889-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 31, 2006. Male patient, 51 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaemia, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cellulitis
, disseminated intravascular coagulation, dysphagia. Mylotarg dosage: 6 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with CYTARABINE, NOVANTRONE, POLYMYXIN B SULPHATE, FAMOTIDINE, SULFAMETHOXAZOLE, ALLORINE, VFEND. Patient was hospitalized. Patient died.Mylotarg Side Effects Report #5085439-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 04, 2006. Male patient, 47 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cerebral haemorrhage, coagulopathy, disease progression, gamma-glutamyltransferase increased, hepatic function abnormal, prothrombin time prolonged, pyrexia. Mylotarg dosage: 6 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with ZANTAC, PRODIF, MAXIPIME, BICARBONATE, OXYCONTIN, MAGNESIUM OXIDE, URSO. Patient died.
Mylotarg Side Effects Report #5019629-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 22, 2006. Male patient, 47 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bilirubin conjugated increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cerebral haemorrhage, coagulopathy, disease progression, gamma-glutamyltransferase increased, haematocrit decreased, haemoglobin decreased. Mylotarg dosage: 6 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ZANTAC, PRODIF, MAXIPIME, BICARBONATE, OXYCONTIN, MAGNESIUM OXIDE, URSO. Patient died.
Mylotarg Side Effects Report #5217067-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 09, 2007. Male patient, 46 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disseminated intravascular coagulation, febrile neutropenia, herpes simplex
, infusion related reaction. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with CYTARABINE, FRAGMIN, KYTRIL, NORVASC. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5220629-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 18, 2007. Male patient, 46 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, disseminated intravascular coagulation, febrile neutropenia, herpes simplex
. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE, FRAGMIN, KYTRIL, NORVASC. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4830680-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 01, 2005. Female patient, 44 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, chills, fibrin degradation products increased, neutrophil count decreased, proctalgia, pyrexia. Mylotarg dosage: unknown. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4839607-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 10, 2005. Female patient, 44 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, chills, disseminated intravascular coagulation, febrile neutropenia, fibrin degradation products increased, gamma-glutamyltransferase increased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE, INTRAVENOUS DRIP. During the same period patient was treated with LAMIVUDINE, COTRIM, DIFLUCAN, CIPROFLOXACIN HYDROCHLORIDE, ZOLPIDEM TARTRATE, MAXIPIME. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4867132-5
Mylotarg side effect was reported by a Physician from JAPAN on Dec 13, 2005. Female patient, 44 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, bone marrow failure, c-reactive protein increased, disseminated intravascular coagulation, febrile neutropenia, fibrin degradation products increased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with LAMIVUDINE, COTRIM, DIFLUCAN, CIPROFLOXACIN HYDROCHLORIDE, ZOLPIDEM TARTRATE, MAXIPIME. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4906948-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 26, 2006. Female patient, 44 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, chills, febrile neutropenia, fibrin degradation products increased, gamma-glutamyltransferase increased. Mylotarg dosage: A SINGLE 9MG/M2 DOSE. During the same period patient was treated with LAMIVUDINE, SULFAMETHOXAZOLE, DIFLUCAN, CIPROFLOXACIN HYDROCHLORIDE, ZOLPIDEM TARTRATE, MAXIPIME. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4917046-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Feb 02, 2006. Female patient, 44 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood stem cell transplant failure, bone marrow failure, c-reactive protein increased, disease progression. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with LAMIVUDINE, SULFAMETHOXAZOLE, DIFLUCAN, CIPROFLOXACIN HYDROCHLORIDE, ZOLPIDEM TARTRATE, MAXIPIME. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #4851395-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 25, 2005. Female patient, 43 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: agranulocytosis, blood alkaline phosphatase increased, blood bilirubin increased, body temperature increased, liver disorder. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with BESTATIN, MEROPEN, VANCOMYCIN HYDROCHLORIDE, PRODIF, ZOVIRAX, OMEPRAZOLE. Patient recovered.
Mylotarg Side Effects Report #4930068-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Feb 16, 2006. Female patient, 43 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, agranulocytosis, anaemia, blood alkaline phosphatase increased, blood bilirubin increased, liver disorder, lymphocyte percentage increased, malignant neoplasm progression, monocyte percentage decreased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with CYTARABINE, BESTATIN, MEROPEN, VANCOMYCIN HYDROCHLORIDE, PRODIF, ZOVIRAX. Patient recovered.
Mylotarg Side Effects Report #4953986-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 10, 2006. Female patient, 43 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, agranulocytosis, anaemia, blood alkaline phosphatase increased, blood bilirubin increased, body temperature increased, lymphocyte percentage increased, malignant neoplasm progression, monocyte percentage increased. Mylotarg dosage: A SINGLE 9 MG/M2 DOSE. During the same period patient was treated with CYTARABINE, BESTATIN, MEROPEN, VANCOMYCIN HYDROCHLORIDE, PRODIF, ZOVIRAX. Patient recovered.
Mylotarg Side Effects Report #4995945-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2006. Female patient, 43 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, agranulocytosis, anaemia, blood alkaline phosphatase increased, blood bilirubin increased, body temperature increased, malignant neoplasm progression, monocyte percentage decreased, neutrophil percentage decreased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with BESTATIN, MEROPEN, VANCOMYCIN HYDROCHLORIDE, PRODIF, ZOVIRAX. Patient recovered.
Mylotarg Side Effects Report #5235843-8
Mylotarg side effect was reported by a Physician from JAPAN on Jan 31, 2007. Male patient, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, disease progression, disseminated intravascular coagulation, dyspnoea, fall
. Mylotarg dosage: unknown. During the same period patient was treated with LENDORMIN, ARTIST, TAKEPRON, MUCOSTA. Patient recovered.Mylotarg Side Effects Report #5251332-9
Mylotarg side effect was reported by a Physician from JAPAN on Feb 19, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, ascites, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, leucine aminopeptidase increased, neutrophil count decreased, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with MAXIPIME, AMIKACIN SULPHATE, TIENAM, CIPROFLOXACIN, OMEPRAL, MEROPENEM. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5253016-X
Mylotarg side effect was reported by a Physician from JAPAN on Feb 19, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, ascites, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, leucine aminopeptidase increased, neutrophil count decreased, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with MAXIPIME, AMIKACIN SULPHATE, TIENAM, CIPROFLOXACIN, OMEPRAL, MEROPENEM. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5291882-2
Mylotarg side effect was reported by a Physician from JAPAN on Mar 29, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, ascites, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, leucine aminopeptidase increased, neutrophil count decreased, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5303031-2
Mylotarg side effect was reported by a Physician from JAPAN on Apr 13, 2007. Male patient, weighting 152.1 lb, was diagnosed with acute myeloid leukaemia recurrent, hyperlipidaemia, diabetes mellitus, constipation
, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, agranulocytosis, ascites, atelectasis, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, chest x-ray abnormal, cholestasis. Mylotarg dosage: unknown. During the same period patient was treated with LIPITOR, ACTOS, MAGNESIUM OXIDE, HUMULIN, BACTRIM, POLYMYXIN B SULPHATE, FUNGIZONE. Patient was hospitalized. Patient died on 01/18/2007.Mylotarg Side Effects Report #5315496-0
Mylotarg side effect was reported by a Physician from JAPAN on Apr 24, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood urea increased, chills. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5343683-4
Mylotarg side effect was reported by a Physician from JAPAN on May 25, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, ascites, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, leucine aminopeptidase increased, neutrophil count decreased, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5448630-2
Mylotarg side effect was reported by a Physician from JAPAN on Sept 06, 2007. Female patient, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, hypoalbuminaemia, neutrophil count decreased, performance status decreased, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with MODACIN, ITRIZOLE, FAMOTIDINE, ZOVIRAX, BAKTAR. Patient recovered.
Mylotarg Side Effects Report #5511142-1
Mylotarg side effect was reported by a Physician from JAPAN on Oct 30, 2007. Male patient, weighting 123.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood pressure diastolic increased, disease progression, gamma-glutamyltransferase increased. Mylotarg dosage: unknown. During the same period patient was treated with BAKTAR, OMEPRAZOLE, PROGRAF, UNIPHYL, BEZATOL, PREDONINE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5645621-3
Mylotarg side effect was reported by a Physician from JAPAN on Feb 18, 2008. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood cholinesterase decreased, blood lactate dehydrogenase increased, blood potassium decreased. Mylotarg dosage: unknown. During the same period patient was treated with PREDNISOLONE, PARIET, BAKTAR, METHOTREXATE, DIFLUCAN, CIPROFLOXACIN, GLYSENNID. Patient was hospitalized and became disabled. Patient recovered.
Mylotarg Side Effects Report #5797024-9
Mylotarg side effect was reported by a Physician from JAPAN on June 23, 2008. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood cholinesterase decreased, blood lactate dehydrogenase increased, blood potassium decreased. Mylotarg dosage: unknown. During the same period patient was treated with PREDNISOLONE, RABEPRAZOLE, BAKTAR, METHOTREXATE, DIFLUCAN, CIPROFLOXACIN, GLYSENNID. Patient was hospitalized and became disabled. Patient recovered.
Mylotarg Side Effects Report #5822128-1
Mylotarg side effect was reported by a Physician from JAPAN on July 16, 2008. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, hypoalbuminaemia. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient died on 12/09/2007.
Mylotarg Side Effects Report #5863189-3
Mylotarg side effect was reported by a Physician from JAPAN on Aug 19, 2008. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood cholinesterase decreased, blood lactate dehydrogenase increased, blood potassium decreased. Mylotarg dosage: unknown. During the same period patient was treated with PREDNISOLONE, RABEPRAZOLE, COTRIM, METHOTREXATE, DIFLUCAN, CIPROFLOXACIN, PURSENNID. Patient was hospitalized and became disabled. Patient recovered.
Mylotarg Side Effects Report #5971499-4
Mylotarg side effect was reported by a Physician from JAPAN on Nov 19, 2008. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, hypoalbuminaemia. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient died on 12/09/2007.
Mylotarg Side Effects Report #6054475-5
Mylotarg side effect was reported by a Physician from JAPAN on Jan 21, 2009. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, hypoalbuminaemia. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient died on 12/09/2007.
Mylotarg Side Effects Report #6130073-X
Mylotarg side effect was reported by a Physician from JAPAN on Mar 19, 2009. Male patient, weighting 119.0 lb, was diagnosed with acute myeloid leukaemia recurrent, anxiety
, insomnia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood urea increased, hypoalbuminaemia, neutropenia, pneumonia , thrombocytopenia. Mylotarg dosage: unknown. During the same period patient was treated with DEPAS, SILECE, ACLACINON, CRAVIT. Patient was hospitalized. Patient died on 08/10/2007.Mylotarg Side Effects Report #4955671-8
Mylotarg side effect was reported by a Health Professional from JAPAN on Mar 10, 2006. Female patient, 85 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatinine increased, blood urea increased, febrile neutropenia, liver disorder, malignant neoplasm progression. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ACLARUBICIN HYDROCHLORIDE, FOSMICIN S, MAXIPIME, VANCOMYCIN, FUNGUARD, PAZUCROSS. Patient recovered.
Mylotarg Side Effects Report #5007450-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 09, 2006. Female patient, 85 years of age, was diagnosed with acute myeloid leukaemia, sepsis
and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood urea increased, disease progression. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CARBENIN, CIPROFLOXACIN, FOSMICIN S, FOSMICIN S, FUNGUARD, MAXIPIME. Patient recovered.Mylotarg Side Effects Report #4676847-3
Mylotarg side effect was reported by a Consumer or non-health professional from on May 18, 2005. Female patient, 82 years of age, weighting 209.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, chills, hyperbilirubinaemia, hypoxia, pyrexia. Mylotarg dosage: 13.16 MG X 1 DOSE, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient recovered.
Mylotarg Side Effects Report #4685737-1
Mylotarg side effect was reported by a Consumer or non-health professional from on May 25, 2005. Male patient, 82 years of age, weighting 209.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, chills, hyperbilirubinaemia, hypoxia, pyrexia. Mylotarg dosage: 13.16 MG X 1 DOSE, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient recovered.
Mylotarg Side Effects Report #4698708-6
Mylotarg side effect was reported by a Consumer or non-health professional from on June 09, 2005. Male patient, 82 years of age, weighting 209.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, chills, hyperbilirubinaemia, hyperhidrosis, hypoxia, pyrexia. Mylotarg dosage: 13.16 MG X 1 DOSE, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient recovered.
Mylotarg Side Effects Report #4947100-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 82 years of age, weighting 209.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, chills, hyperbilirubinaemia, hyperhidrosis, hypoxia, infusion related reaction, pyrexia. Mylotarg dosage: 13.16 MG X 1 DOSE; INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient recovered.
Mylotarg Side Effects Report #4742424-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 26, 2005. Male patient, 81 years of age, weighting 187.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, pyrexia, weight increased. Mylotarg dosage: unknown. During the same period patient was treated with CALCIUM, XANAX, MAGNESIUM, PROTONIX, ALLOPURINOL, ZOFRAN, CYTARABINE. Patient recovered.
Mylotarg Side Effects Report #5105261-1
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Aug 28, 2006. Female patient, 77 years of age, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, apparent life threatening event, aspartate aminotransferase increased, bacterial infection
, blood alkaline phosphatase increased, blood bilirubin increased, bronchoalveolar lavage abnormal, culture positive, haemoptysis. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ELSPAR, CYTARABINE, NOVANTRONE. Patient was hospitalized. Patient died on 02/06/2006.Mylotarg Side Effects Report #4870092-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 13, 2002. Female patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, disease progression, platelet count decreased, pneumonia fungal. Mylotarg dosage: 8.297 MG 1X PER 1 DAY, INTRAVENOUS; 5.53 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE, ACYCLOVIR, PERIDEX, PREVACID, FLUCONAZOLE, GENTAMICIN, LEVOFLOXACIN. Patient died on 09/05/2002.
Mylotarg Side Effects Report #4875157-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 23, 2005. Male patient, 77 years of age, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blast cell count increased, blood alkaline phosphatase increased, blood potassium decreased, csf protein increased, disease progression, febrile neutropenia, haemoglobin decreased, headache
. Mylotarg dosage: unknown. During the same period patient was treated with FOLIC ACID, ACYCLOVIR, NORVASC, ACCUPRIL, ATENOLOL, VITAMINS. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4944146-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 28, 2006. Female patient, 77 years of age, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacterial infection
, blood alkaline phosphatase increased, blood culture positive, haemoptysis, liver function test abnormal, neutropenia, pneumonia fungal. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ELSPAR, CYTARABINE, NOVANTRONE. Patient was hospitalized. Patient died on 02/06/2006.Mylotarg Side Effects Report #4969295-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 23, 2006. Female patient, 77 years of age, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacterial infection
, blood alkaline phosphatase increased, blood bilirubin increased, haemoptysis, neutrophil count decreased, pneumonia fungal, pyrexia. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ELSPAR, CYTARABINE, NOVANTRONE. Patient was hospitalized. Patient died on 02/06/2006.Mylotarg Side Effects Report #4949325-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Female patient, 76 years of age, weighting 214.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, chills, disease progression, infusion related reaction, weight increased. Mylotarg dosage: 17 MG, INTRAVENOUS. Patient recovered.
Mylotarg Side Effects Report #5105036-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 29, 2006. Male patient, 75 years of age, weighting 181.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood glucose increased, blood potassium decreased. Mylotarg dosage: unknown. During the same period patient was treated with SERTRALINE, FUROSEMIDE, FAMOTIDINE, METOCLOPRAMIDE, ITRACONAZOLE, CIPROFLOXACIN, ACYCLOVIR. Patient recovered.
Mylotarg Side Effects Report #4627228-X
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Male patient, 75 years of age, weighting 181.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood glucose increased, blood potassium decreased. Mylotarg dosage: unknown. During the same period patient was treated with SERTRALINE, FUROSEMIDE, FAMOTIDINE, METOCLOPRAMIDE, ITRACONAZOLE, CIPROFLOXACIN, ACYCLOVIR, IMIPENEM. Patient recovered.
Mylotarg Side Effects Report #4663708-9
Mylotarg side effect was reported by a Consumer or non-health professional from on May 03, 2005. Male patient, 75 years of age, weighting 181.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood glucose increased, blood potassium decreased, blood potassium increased. Mylotarg dosage: unknown. During the same period patient was treated with SERTRALINE, FUROSEMIDE, FAMOTIDINE, METOCLOPRAMIDE, ITRACONAZOLE, CIPROFLOXACIN, ACYCLOVIR. Patient recovered.
Mylotarg Side Effects Report #4780622-9
Mylotarg side effect was reported by a Physician from UNITED STATES on Sept 12, 2005. Female patient, 75 years of age, weighting 191.2 lb, was diagnosed with acute myeloid leukaemia, leukaemia recurrent, herpes virus infection and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, cardiomegaly, chest pain
, chills, haematocrit decreased, haemoglobin decreased, herpes virus infection. Mylotarg dosage: 16 MG 1X PER 1 DAY, INTRAVENOUS; 16 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ACYCLOVIR. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4947765-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 75 years of age, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, chills, hypotension, infusion related reaction, oxygen saturation decreased, pyrexia. Mylotarg dosage: 15 MG 1X PER 1 DAY, INTRAVENOUS; SEE IMAGE. Patient recovered.
Mylotarg Side Effects Report #5073616-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 28, 2006. Female patient, 73 years of age, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, blood alkaline phosphatase increased, blood calcium decreased, blood chloride increased, blood creatine increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, blood phosphorus decreased, blood potassium decreased. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with PREDNISONE, PREVACID, SENOKOT, VITAMINS NOS, ZOSYN, DIFLUCAN, LEVAQUIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5127211-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 27, 2006. Female patient, 73 years of age, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, blast cell count increased, blood alkaline phosphatase increased, blood calcium decreased, blood chloride increased, blood creatinine increased, blood glucose decreased, blood glucose increased, blood lactate dehydrogenase increased. Mylotarg dosage: 17 MG 1X PER 1 DAY; INTRAVENOUS. During the same period patient was treated with PREDNISONE, PREVACID, SENOKOT, VITAMINS NOS, ZOSYN, DIFLUCAN, LEVAQUIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4952650-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 17, 2004. Female patient, 72 years of age, weighting 121.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrial flutter, blood alkaline phosphatase increased, blood urea increased, bradycardia, chills, diarrhoea, dizziness
. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with NORVASC, ACTIVASE, ALLEGRA, DIFLUCAN, MORPHINE SULPHATE, PROTONIX, SERTRALINE. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4995511-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 21, 2006. Female patient, 72 years of age, weighting 121.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrial flutter, blood alkaline phosphatase increased, blood urea increased, bradycardia, diarrhoea, febrile neutropenia, hypokalaemia. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS. During the same period patient was treated with NORVASC, ACTIVASE, ALLEGRA, DIFLUCAN, MORPHINE SULPHATE, PROTONIX, SERTRALINE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4978538-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2006. Female patient, 71 years of age, weighting 192.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, disease progression, dyspnoea, weight increased. Mylotarg dosage: unknown. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5052858-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 29, 2006. Male patient, 70 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase, bone marrow transplant
, chills, dehydration. Mylotarg dosage: 18.9 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 01/08/2006.Mylotarg Side Effects Report #5056539-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2006. Male patient, 70 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, bone marrow transplant
, chills. Mylotarg dosage: 18.9 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 01/08/2006.Mylotarg Side Effects Report #5136050-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 16, 2006. Female patient, 70 years of age, weighting 218.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, diarrhoea, pyrexia, weight increased. Mylotarg dosage: unknown. During the same period patient was treated with ALLOPURINOL, SYNTHROID, ZETIA, NORVASC, ACETAMINOPHEN, VANCOMYCIN, TOBRAMYCIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4616368-7
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 07, 2005. Male patient, 70 years of age, weighting 180.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, chills, condition aggravated, dyspnoea, pyrexia, thrombocytopenia, weight increased. Mylotarg dosage: unknown. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, MORPHINE SULPHATE, AMBIEN, TYLENOL, ZOSYN. Patient recovered.
Mylotarg Side Effects Report #4627225-4
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 18, 2005. Male patient, 70 years of age, weighting 180.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: apnoea, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, chills, condition aggravated, dyspnoea, hyperhidrosis. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, MORPHINE SULPHATE, AMBIEN, TYLENOL, ZOSYN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4631234-9
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 29, 2005. Male patient, 70 years of age, weighting 180.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, chills, condition aggravated, dyspnoea, hyperhidrosis, international normalised ratio increased, pyrexia. Mylotarg dosage: unknown. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, AMBIEN, TYLENOL, ZOSYN, GENTAMICIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4949629-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 70 years of age, weighting 180.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, condition aggravated, dyspnoea, infusion related reaction, thrombocytopenia, weight increased. Mylotarg dosage: unknown. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, MORPHINE SULPHATE, AMBIEN, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4952605-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 09, 2006. Male patient, 70 years of age, weighting 167.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, infusion related reaction, pyrexia, weight increased. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE. Patient recovered.
Mylotarg Side Effects Report #5010738-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on May 12, 2006. Male patient, 70 years of age, weighting 167.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, infusion related reaction, pyrexia, weight increased. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE. Patient recovered.
Mylotarg Side Effects Report #4744368-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2005. Male patient, 69 years of age, weighting 179.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, pyrexia, weight increased. Mylotarg dosage: unknown. Patient recovered.
Mylotarg Side Effects Report #4962833-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 20, 2006. Female patient, 69 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease progression, febrile neutropenia, herpes zoster, hypokalaemia. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with MEROPEN, GRAVIT, DIFLUCAN, FAMOTIDINE, PREDNISOLONE, MAGNESIUM OXIDE, BROTIZOLAM. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5032005-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 08, 2006. Female patient, 69 years of age, was diagnosed with acute myeloid leukaemia, herpes zoster and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease progression, disseminated intravascular coagulation, febrile neutropenia, hepatic function abnormal. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with ACYCLOVIR, ETOPOSIDE, MEROPEN, LEVOFLOXACIN, DIFLUCAN, FAMOTIDINE, PREDNISOLONE, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5098667-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 24, 2006. Male patient, 68 years of age, weighting 167.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, clostridium colitis, enterococcal infection, febrile neutropenia. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE, CANCIDAS, FLUCONAZOLE, VANCOMYCIN, CEFTAZIDIME, ALBUTEROL, VITAMINS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4681377-9
Mylotarg side effect was reported by a Consumer or non-health professional from on May 19, 2005. Female patient, 68 years of age, weighting 161.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, aspartate aminotransferase increased, bacteraemia, blood alkaline phosphatase increased, blood bilirubin increased, chills, decreased appetite, dyspnoea, enterobacter infection. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE, ACYCLOVIR, PROTONIX. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4754314-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 19, 2005. Female patient, 67 years of age, weighting 117.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, dyspnoea, hepatotoxicity, malignant neoplasm progression, pleural effusion. Mylotarg dosage: 9.1 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 04/03/2004.
Mylotarg Side Effects Report #5223121-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 11, 2007. Female patient, 66 years of age, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disseminated intravascular coagulation, dysgeusia, fatigue, gamma-glutamyltransferase increased, herpes simplex
. Mylotarg dosage: 6 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with FAMOTIDINE, ISEPACIN, CLINDAMYCIN PHOSPHATE, NEUPOGEN, BAKTAR, MEROPEN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5103248-6
Mylotarg side effect was reported by a Health Professional from JAPAN on Aug 28, 2006. Female patient, 66 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disseminated intravascular coagulation, dysgeusia, fatigue, gamma-glutamyltransferase increased, herpes simplex
. Mylotarg dosage: unknown. During the same period patient was treated with FAMOTIDINE, SULFAMETHOXAZOLE, VFEND, MEROPEN, ISEPACIN, CLINDAMYCIN PHOSPHATE. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5128900-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 09, 2006. Female patient, 66 years of age, weighting 151.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, disease progression, febrile neutropenia, fluid overload, haemoglobin decreased, infusion related reaction. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CIPRO, DIFLUCAN, ACYCLOVIR, PROZAC, LOPRESSOR, PREVACID, COUMADIN. Patient was hospitalized. Patient died on 07/19/2003.
Mylotarg Side Effects Report #4949624-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Female patient, 66 years of age, weighting 151.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood urea increased, disease progression, febrile neutropenia, fluid overload, haemoglobin decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN, DIFLUCAN, ACYCLOVIR, PROZAC, LOPRESSOR, PREVACID, COUMADIN. Patient was hospitalized. Patient died on 07/19/2003.
Mylotarg Side Effects Report #5073159-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 26, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, disease progression, dyspnoea. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS. Patient died on 02/16/2006.
Mylotarg Side Effects Report #5106489-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 30, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood urea increased, decreased appetite, dizziness
, dyspnoea. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS. Patient died on 02/16/2006.Mylotarg Side Effects Report #5119380-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, disease progression. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS. Patient died on 02/16/2006.
Mylotarg Side Effects Report #5122893-5
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Sept 27, 2006. Male patient, 65 years of age, weighting 212.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase decreased, blood alkaline phosphatase increased, blood bilirubin increased, weight increased. Mylotarg dosage: 19 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with IMIPENEM, TOBRAMYCIN, REGLAN, ACETAMINOPHEN, GUAIFENESIN, PERCOCET, ACYCLOVIR. Patient recovered.
Mylotarg Side Effects Report #4961840-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 17, 2006. Male patient, 65 years of age, weighting 188.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood alkaline phosphatase increased, blood chloride increased, chills, dyspnoea, haemoglobin decreased, infusion related reaction, platelet count decreased, stridor. Mylotarg dosage: 18.6 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4620728-8
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 15, 2004. Male patient, 63 years of age, weighting 239.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain upper, blood alkaline phosphatase increased, chills, cough, febrile neutropenia, haemoglobin decreased, nausea
, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with DILANTIN, PHENOBRBITAL, LISINOPRIL, LASIX, TOPROL. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4753502-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2005. Male patient, 63 years of age, weighting 239.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain upper, blood alkaline phosphatase increased, body temperature increased, chills, cough, febrile neutropenia, haemoglobin decreased, nausea
, platelet count decreased. Mylotarg dosage: 20 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with DILANTIN, PHENOBARBITAL, LISINOPRIL, LASIX, TOPROL. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4863969-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 07, 2005. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acidosis, activated partial thromboplastin time prolonged, acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease progression, disseminated intravascular coagulation. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with METHOTREXATE. Patient died.
Mylotarg Side Effects Report #4869686-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 20, 2005. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acidosis, acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disseminated intravascular coagulation, febrile neutropenia, gamma-glutamyltransferase increased. Mylotarg dosage: 9 MG/M 2 1X PER 1 DAY. Patient died.
Mylotarg Side Effects Report #4947758-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 63 years of age, weighting 189.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, chills, hyperglycaemia, infusion related reaction. Mylotarg dosage: 13 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient recovered.
Mylotarg Side Effects Report #4949615-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2006. Male patient, 63 years of age, weighting 239.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain upper, blood alkaline phosphatase increased, chills, cough, febrile neutropenia, haemoglobin decreased, infusion related reaction, nausea
, platelet count decreased. Mylotarg dosage: 20 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with DILANTIN, PHENOBARBITAL, LASIX, TOPROL. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5008804-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 11, 2006. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acidosis, activated partial thromboplastin time prolonged, acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blast cell count increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with METHOTREXATE, OMEGACIN. Patient was hospitalized. Patient died.